MedTrace Logo

Concurrent Assessment of Skeletal Muscle Mass and Synthesis/Breakdown in Old Age

NCT04114383 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2020-03-25

No results posted yet for this study

Summary

This study involves minimally-invasive techniques to measure muscle mass, muscle protein breakdown and synthesis simultaneously in older age.

Conditions

Interventions

OTHER

D3-Creatine

30mg D3-Creatine to measure muscle mass

OTHER

Deuterium Oxide

D2O provided to measure muscle protein synthesis

OTHER

D3-3-methylhistidine

D3-3-methylhistidine is provided to measure muscle protein breakdown

Sponsors & Collaborators

  • Abbeyfield

    collaborator UNKNOWN

  • University of Nottingham

    lead OTHER

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-07
Primary Completion
2020-01-31
Completion
2020-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04114383 on ClinicalTrials.gov